{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:23:42Z","timestamp":1790659422898,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32-DK104687"],"award-info":[{"award-number":["T32-DK104687"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23-DK123378"],"award-info":[{"award-number":["K23-DK123378"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fibroblast growth factor 23 (FGF23) is a bone-derived hormone that plays a central role in chronic kidney disease-mineral bone disorder and is associated with CKD progression and cardiovascular morbidity. Factors related to CKD-associated anemia, including iron deficiency, can increase FGF23 production. This study aimed to assess whether anemia and\/or iron deficiency are associated with increased circulating concentrations of FGF23 in the large, well-characterized Chronic Kidney Disease in Children (CKiD) study cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Hemoglobin concentrations, iron parameters, C-terminal (total) FGF23, intact FGF23, and relevant covariables were measured in cross-sectional analysis of CKiD study subjects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In 493 pediatric patients with CKD (median [interquartile range] age 13 [9,\u00a016] years), the\u00a0median estimated glomerular filtration rate was 48 [35,\u00a061] ml\/min\/1.73 m<jats:sup>2<\/jats:sup>, and 103 patients (21%) were anemic. Anemic subjects had higher total FGF23 concentrations than non-anemic subjects (204 [124,\u00a0390] vs. 109 [77,\u00a0168] RU\/ml, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). In multivariable linear regression modeling, anemia was independently associated with higher total FGF23, after adjustment for demographic, kidney-related, mineral metabolism, and inflammatory covariables (standardized \u03b2 (95% confidence interval) 0.10 (0.04,\u00a00.17), <jats:italic>p<\/jats:italic>\u2009=\u20090.002). In the subset of subjects\u00a0with available iron parameters (n\u2009=\u2009191), iron deficiency was not associated with significantly higher total FGF23 concentrations. In the subgroup that had measurements of both total and intact FGF23 (n\u2009=\u2009185), in fully adjusted models, anemia was significantly associated with higher total FGF23 (standardized \u03b2 (95% CI) 0.16 (0.04,\u00a00.27), <jats:italic>p<\/jats:italic>\u2009=\u20090.008) but not intact FGF23 (standardized \u03b2 (95% CI) 0.02 (\u22120.12, 0.15), <jats:italic>p<\/jats:italic>\u2009=\u20090.81).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In this cohort of pediatric patients with CKD, anemia was associated with increased total FGF23 levels but was not independently associated with elevated intact FGF23, suggesting possible effects on both FGF23 production and cleavage. Further studies are warranted to investigate non-mineral factors affecting FGF23 production and metabolism in CKD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00467-023-06160-0","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T16:02:36Z","timestamp":1695744156000},"page":"837-847","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Associations between anemia and FGF23 in the CKiD study"],"prefix":"10.1007","volume":"39","author":[{"given":"Elizabeth","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra M.","family":"Klomhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marciana L.","family":"Laster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Furth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Warady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro B.","family":"Salusky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5886-8078","authenticated-orcid":false,"given":"Mark R.","family":"Hanudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"6160_CR1","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.bone.2009.08.008","volume":"45","author":"RC Pereira","year":"2009","unstructured":"Pereira RC, Juppner H, Azucena-Serrano CE, Yadin O, Salusky IB, Wesseling-Perry K (2009) Patterns of FGF-23, DMP1, and MEPE expression in patients with chronic kidney disease. Bone 45:1161\u20131168","journal-title":"Bone"},{"key":"6160_CR2","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS, Gutierrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, Lash JP, Hsu CY, Leonard MB, Wolf M (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79:1370\u20131378","journal-title":"Kidney Int"},{"key":"6160_CR3","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","volume":"64","author":"T Larsson","year":"2003","unstructured":"Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB (2003) Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 64:2272\u20132279","journal-title":"Kidney Int"},{"key":"6160_CR4","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1681\/ASN.2005010052","volume":"16","author":"O Gutierrez","year":"2005","unstructured":"Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Juppner H, Wolf M (2005) Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol 16:2205\u20132215","journal-title":"J Am Soc Nephrol"},{"key":"6160_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2215\/CJN.05840513","volume":"9","author":"AA Portale","year":"2014","unstructured":"Portale AA, Wolf M, Juppner H, Messinger S, Kumar J, Wesseling-Perry K, Schwartz GJ, Furth SL, Warady BA, Salusky IB (2014) Disordered FGF23 and mineral metabolism in children with CKD. Clin J Am Soc Nephrol 9:344\u2013353","journal-title":"Clin J Am Soc Nephrol"},{"key":"6160_CR6","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1681\/ASN.2006080936","volume":"18","author":"D Fliser","year":"2007","unstructured":"Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F, Group MS, Kuen E, Konig P, Kraatz G, Mann JF, Muller GA, Kohler H, Riegler P (2007) Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study. J Am Soc Nephrol 18:2600\u20132608","journal-title":"J Am Soc Nephrol"},{"key":"6160_CR7","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1001\/jama.2011.826","volume":"305","author":"T Isakova","year":"2011","unstructured":"Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutierrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M, Chronic Renal Insufficiency Cohort Study Group (2011) Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 305:2432\u20132439","journal-title":"JAMA"},{"key":"6160_CR8","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.2215\/CJN.02110216","volume":"11","author":"AA Portale","year":"2016","unstructured":"Portale AA, Wolf MS, Messinger S, Perwad F, Juppner H, Warady BA, Furth SL, Salusky IB (2016) Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. Clin J Am Soc Nephrol 11:1989\u20131998","journal-title":"Clin J Am Soc Nephrol"},{"key":"6160_CR9","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutierrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro OM, Kusek JW, Keane MG, Wolf M (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121:4393\u20134408","journal-title":"J Clin Invest"},{"key":"6160_CR10","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Gutierrez","year":"2009","unstructured":"Gutierrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, deFilippi C, Wolf M (2009) Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 119:2545\u20132552","journal-title":"Circulation"},{"key":"6160_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2215\/CJN.02110217","volume":"13","author":"MM Mitsnefes","year":"2018","unstructured":"Mitsnefes MM, Betoko A, Schneider MF, Salusky IB, Wolf MS, Juppner H, Warady BA, Furth SL, Portale AA (2018) FGF23 and Left Ventricular Hypertrophy in Children with CKD. Clin J Am Soc Nephrol 13:45\u201352","journal-title":"Clin J Am Soc Nephrol"},{"key":"6160_CR12","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1172\/JCI83470","volume":"126","author":"J Rossaint","year":"2016","unstructured":"Rossaint J, Oehmichen J, Van Aken H, Reuter S, Pavenstadt HJ, Meersch M, Unruh M, Zarbock A (2016) FGF23 signaling impairs neutrophil recruitment and host defense during CKD. J Clin Invest 126:962\u2013974","journal-title":"J Clin Invest"},{"key":"6160_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1681\/ASN.2014101009","volume":"27","author":"M Chonchol","year":"2016","unstructured":"Chonchol M, Greene T, Zhang Y, Hoofnagle AN, Cheung AK (2016) Low vitamin d and high fibroblast growth factor 23 serum levels associate with infectious and cardiac deaths in the HEMO study. J Am Soc Nephrol 27:227\u2013237","journal-title":"J Am Soc Nephrol"},{"key":"6160_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Gutierrez","year":"2008","unstructured":"Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, Wolf M (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584\u2013592","journal-title":"N Engl J Med"},{"key":"6160_CR15","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s11914-018-0492-2","volume":"16","author":"MR Hanudel","year":"2018","unstructured":"Hanudel MR, Laster M, Salusky IB (2018) Non-renal-Related Mechanisms of FGF23 Pathophysiology. Curr Osteoporos Rep 16:724\u2013729","journal-title":"Curr Osteoporos Rep"},{"key":"6160_CR16","doi-asserted-by":"publisher","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","volume":"108","author":"EG Farrow","year":"2011","unstructured":"Farrow EG, Yu X, Summers LJ, Davis SI, Fleet JC, Allen MR, Robling AG, Stayrook KR, Jideonwo V, Magers MJ, Garringer HJ, Vidal R, Chan RJ, Goodwin CB, Hui SL, Peacock M, White KE (2011) Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc Natl Acad Sci U S A 108:E1146-1155","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6160_CR17","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/jbmr.2049","volume":"29","author":"EL Clinkenbeard","year":"2014","unstructured":"Clinkenbeard EL, Farrow EG, Summers LJ, Cass TA, Roberts JL, Bayt CA, Lahm T, Albrecht M, Allen MR, Peacock M, White KE (2014) Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice. J Bone Miner Res 29:361\u2013369","journal-title":"J Bone Miner Res"},{"key":"6160_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ki.2015.290","volume":"89","author":"V David","year":"2016","unstructured":"David V, Martin A, Isakova T, Spaulding C, Qi L, Ramirez V, Zumbrennen-Bullough KB, Sun CC, Lin HY, Babitt JL, Wolf M (2016) Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney Int 89:135\u2013146","journal-title":"Kidney Int"},{"key":"6160_CR19","doi-asserted-by":"publisher","first-page":"F1369","DOI":"10.1152\/ajprenal.00281.2016","volume":"311","author":"MR Hanudel","year":"2016","unstructured":"Hanudel MR, Chua K, Rappaport M, Gabayan V, Valore E, Goltzman D, Ganz T, Nemeth E, Salusky IB (2016) Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice. Am J Physiol Renal Physiol 311:F1369\u2013F1377","journal-title":"Am J Physiol Renal Physiol"},{"key":"6160_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2215\/CJN.01670408","volume":"4","author":"S Fishbane","year":"2009","unstructured":"Fishbane S, Pollack S, Feldman HI, Joffe MM (2009) Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988\u20132004. Clin J Am Soc Nephrol 4:57\u201361","journal-title":"Clin J Am Soc Nephrol"},{"key":"6160_CR21","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s00467-011-1946-2","volume":"26","author":"R Baracco","year":"2011","unstructured":"Baracco R, Saadeh S, Valentini R, Kapur G, Jain A, Mattoo TK (2011) Iron deficiency in children with early chronic kidney disease. Pediatr Nephrol 26:2077\u20132208","journal-title":"Pediatr Nephrol"},{"key":"6160_CR22","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.3324\/haematol.2017.167882","volume":"102","author":"EL Clinkenbeard","year":"2017","unstructured":"Clinkenbeard EL, Hanudel MR, Stayrook KR, Appaiah HN, Farrow EG, Cass TA, Summers LJ, Ip CS, Hum JM, Thomas JC, Ivan M, Richine BM, Chan RJ, Clemens TL, Schipani E, Sabbagh Y, Xu L, Srour EF, Alvarez MB, Kacena MA, Salusky IB, Ganz T, Nemeth E, White KE (2017) Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow. Haematologica 102:e427\u2013e430","journal-title":"Haematologica"},{"key":"6160_CR23","doi-asserted-by":"publisher","first-page":"F132","DOI":"10.1152\/ajprenal.00081.2017","volume":"314","author":"S Rabadi","year":"2018","unstructured":"Rabadi S, Udo I, Leaf DE, Waikar SS, Christov M (2018) Acute blood loss stimulates fibroblast growth factor 23 production. Am J Physiol Renal Physiol 314:F132\u2013F139","journal-title":"Am J Physiol Renal Physiol"},{"key":"6160_CR24","doi-asserted-by":"crossref","unstructured":"Flamme I, Ellinghaus P, Urrego D, Kruger T (2017) FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase. PLoS One 12:e0186979","DOI":"10.1371\/journal.pone.0186979"},{"key":"6160_CR25","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.kint.2017.11.018","volume":"93","author":"L Toro","year":"2018","unstructured":"Toro L, Barrientos V, Leon P, Rojas M, Gonzalez M, Gonzalez-Ibanez A, Illanes S, Sugikawa K, Abarzua N, Bascunan C, Arcos K, Fuentealba C, Tong AM, Elorza AA, Pinto ME, Alzamora R, Romero C, Michea L (2018) Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury. Kidney Int 93:1131\u20131141","journal-title":"Kidney Int"},{"key":"6160_CR26","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00424-018-2171-7","volume":"470","author":"A Daryadel","year":"2018","unstructured":"Daryadel A, Bettoni C, Haider T, Imenez Silva PH, Schnitzbauer U, Pastor-Arroyo EM, Wenger RH, Gassmann M, Wagner CA (2018) Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men. Pflugers Arch 470:1569\u20131582","journal-title":"Pflugers Arch"},{"key":"6160_CR27","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1093\/ndt\/gfy189","volume":"34","author":"MR Hanudel","year":"2019","unstructured":"Hanudel MR, Eisenga MF, Rappaport M, Chua K, Qiao B, Jung G, Gabayan V, Gales B, Ramos G, de Jong MA, van Zanden JJ, de Borst MH, Bakker SJL, Nemeth E, Salusky IB, Gaillard C, Ganz T (2019) Effects of erythropoietin on fibroblast growth factor 23 in mice and humans. Nephrol Dial Transplant 34:2057\u20132065","journal-title":"Nephrol Dial Transplant"},{"key":"6160_CR28","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1093\/ndt\/gfm316","volume":"22","author":"F Artunc","year":"2007","unstructured":"Artunc F, Risler T (2007) Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease. Nephrol Dial Transplant 22:2900\u20132908","journal-title":"Nephrol Dial Transplant"},{"key":"6160_CR29","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.2215\/CJN.01941205","volume":"1","author":"SL Furth","year":"2006","unstructured":"Furth SL, Cole SR, Moxey-Mims M, Kaskel F, Mak R, Schwartz G, Wong C, Munoz A, Warady BA (2006) Design and methods of the chronic kidney disease in children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 1:1006\u20131015","journal-title":"Clin J Am Soc Nephrol"},{"key":"6160_CR30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/kisup.2012.37","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group (2012) KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl 2:279\u2013335","journal-title":"Kidney Int Suppl"},{"key":"6160_CR31","first-page":"1462","volume":"81","author":"J Janus","year":"2010","unstructured":"Janus J, Moerschel SK (2010) Evaluation of anemia in children. Am Fam Physician 81:1462\u20131471","journal-title":"Am Fam Physician"},{"key":"6160_CR32","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1258\/acb.2012.011274","volume":"49","author":"DC Fischer","year":"2012","unstructured":"Fischer DC, Mischek A, Wolf S, Rahn A, Salweski B, Kundt G, Haffner D (2012) Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase. Ann Clin Biochem 49:546\u2013553","journal-title":"Ann Clin Biochem"},{"key":"6160_CR33","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.kint.2020.10.047","volume":"99","author":"CB Pierce","year":"2021","unstructured":"Pierce CB, Munoz A, Ng DK, Warady BA, Furth SL, Schwartz GJ (2021) Age- and sex-dependent clinical equations to estimate glomerular filtration rates in children and young adults with chronic kidney disease. Kidney Int 99:948\u2013956","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"6160_CR34","first-page":"584","volume":"5","author":"L Ardeshirpour","year":"2007","unstructured":"Ardeshirpour L, Cole DE, Carpenter TO (2007) Evaluation of bone and mineral disorders. Pediatr Endocrinol Rev 5(Suppl 1):584\u2013598","journal-title":"Pediatr Endocrinol Rev"},{"key":"6160_CR35","doi-asserted-by":"crossref","unstructured":"Stauffer ME, Fan T (2014) Prevalence of anemia in chronic kidney disease in the United States. PLoS One 9:e84943","DOI":"10.1371\/journal.pone.0084943"},{"key":"6160_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/ckj\/sfac240","volume":"16","author":"CP Kovesdy","year":"2023","unstructured":"Kovesdy CP, Davis JR, Duling I, Little DJ (2023) Prevalence of anaemia in adults with chronic kidney disease in a representative sample of the United States population: analysis of the 1999\u20132018 National Health and Nutrition Examination Survey. Clin Kidney J 16:303\u2013311","journal-title":"Clin Kidney J"},{"key":"6160_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s00223-022-00987-9","volume":"112","author":"AC Heijboer","year":"2023","unstructured":"Heijboer AC, Cavalier E (2023) The measurement and interpretation of fibroblast growth factor 23 (FGF23) concentrations. Calcif Tissue Int 112:258\u2013270","journal-title":"Calcif Tissue Int"},{"key":"6160_CR38","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1681\/ASN.2016121350","volume":"28","author":"MF Eisenga","year":"2017","unstructured":"Eisenga MF, van Londen M, Leaf DE, Nolte IM, Navis G, Bakker SJL, de Borst MH, Gaillard C (2017) C-terminal fibroblast growth factor 23, iron deficiency, and mortality in renal transplant recipients. J Am Soc Nephrol 28:3639\u20133646","journal-title":"J Am Soc Nephrol"},{"key":"6160_CR39","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.kint.2021.07.013","volume":"100","author":"RC Mehta","year":"2021","unstructured":"Mehta RC, Cho ME, Cai X, Lee J, Chen J, He J, Flack J, Shafi T, Saraf SL, David V, Feldman HI, Isakova T, Wolf M, CRIC Study Investigators (2021) Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease. Kidney Int 100:1292\u20131302","journal-title":"Kidney Int"},{"key":"6160_CR40","doi-asserted-by":"publisher","first-page":"e011130","DOI":"10.1161\/JAHA.118.011130","volume":"8","author":"MF Eisenga","year":"2019","unstructured":"Eisenga MF, Emans ME, van der Putten K, Cramer MJ, Diepenbroek A, Velthuis BK, Doevendans PA, Verhaar MC, Joles JA, Bakker SJL, Nolte IM, Braam B, Gaillard C (2019) Epoetin beta and c-terminal fibroblast growth factor 23 in patients with chronic heart failure and chronic kidney disease. J Am Heart Assoc 8:e011130","journal-title":"J Am Heart Assoc"},{"key":"6160_CR41","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrneph.2012.116","volume":"8","author":"H Komaba","year":"2012","unstructured":"Komaba H, Fukagawa M (2012) The role of FGF23 in CKD\u2013with or without Klotho. Nat Rev Nephrol 8:484\u2013490","journal-title":"Nat Rev Nephrol"},{"key":"6160_CR42","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/ASN.2011111078","volume":"23","author":"JL Babitt","year":"2012","unstructured":"Babitt JL, Lin HY (2012) Mechanisms of anemia in CKD. J Am Soc Nephrol 23:1631\u20131634","journal-title":"J Am Soc Nephrol"},{"key":"6160_CR43","doi-asserted-by":"publisher","first-page":"9795","DOI":"10.1074\/jbc.M113.527150","volume":"289","author":"LM Coe","year":"2014","unstructured":"Coe LM, Madathil SV, Casu C, Lanske B, Rivella S, Sitara D (2014) FGF-23 is a negative regulator of prenatal and postnatal erythropoiesis. J Biol Chem 289:9795\u20139810","journal-title":"J Biol Chem"},{"key":"6160_CR44","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1096\/fj.201700667R","volume":"32","author":"R Agoro","year":"2018","unstructured":"Agoro R, Montagna A, Goetz R, Aligbe O, Singh G, Coe LM, Mohammadi M, Rivella S, Sitara D (2018) Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia. FASEB J 32:3752\u20133764","journal-title":"FASEB J"},{"key":"6160_CR45","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.2215\/CJN.03950417","volume":"12","author":"R Mehta","year":"2017","unstructured":"Mehta R, Cai X, Hodakowski A, Lee J, Leonard M, Ricardo A, Chen J, Hamm L, Sondheimer J, Dobre M, David V, Yang W, Go A, Kusek JW, Feldman H, Wolf M, Isakova T, CRIC Study Investigators (2017) Fibroblast growth factor 23 and anemia in the chronic renal insufficiency cohort study. Clin J Am Soc Nephrol 12:1795\u20131803","journal-title":"Clin J Am Soc Nephrol"},{"key":"6160_CR46","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.1007\/s00467-021-05081-0","volume":"36","author":"B Limm-Chan","year":"2021","unstructured":"Limm-Chan B, Wesseling-Perry K, Pearl MH, Jung G, Tsai-Chambers E, Weng PL, Hanudel MR (2021) Associations among erythropoietic, iron-related, and FGF23 parameters in pediatric kidney transplant recipients. Pediatr Nephrol 36:3241\u20133249","journal-title":"Pediatr Nephrol"},{"key":"6160_CR47","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00467-023-05903-3","volume":"38","author":"V Karava","year":"2023","unstructured":"Karava V, Dotis J, Kondou A, Christoforidis A, Taparkou A, Farmaki E, Economou M, Printza N (2023) Fibroblast growth-factor 23 and vitamin D are associated with iron deficiency and anemia in children with chronic kidney disease. Pediatr Nephrol 38:2771\u20132779","journal-title":"Pediatr Nephrol"},{"key":"6160_CR48","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1007\/s10157-022-02238-5","volume":"26","author":"N Yamamura-Miyazaki","year":"2022","unstructured":"Yamamura-Miyazaki N, Michigami T, Ozono K, Yamamoto K, Hasuike Y (2022) Factors associated with 1-year changes in serum fibroblast growth factor 23 levels in pediatric patients with chronic kidney disease. Clin Exp Nephrol 26:1014\u20131021","journal-title":"Clin Exp Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-06160-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-023-06160-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-06160-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T13:03:43Z","timestamp":1706274223000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-023-06160-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["6160"],"URL":"https:\/\/doi.org\/10.1007\/s00467-023-06160-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"assertion":[{"value":"18 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}